arginine and plerixafor

arginine has been researched along with plerixafor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Barretina, J; Blanco, J; Cabrera, C; Clotet, B; Esté, JA; Evdokimov, AG; Gutiérrez, A; Lapidot, A; Litovchick, A1
Fruehauf, S; Seeger, T; Topaly, J1
Berchanski, A; Borkow, G; Kollet, O; Lapidot, A; Lapidot, T; Pal, B; Peled, A1

Reviews

2 review(s) available for arginine and plerixafor

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Innovative strategies for PBPC mobilization.
    Cytotherapy, 2005, Volume: 7, Issue:5

    Topics: Anti-HIV Agents; Arginine; Benzhydryl Compounds; Benzylamines; Cell Adhesion Molecules; Chemokine CXCL12; Chemokine CXCL2; Chemokines, CXC; Cyclams; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Models, Immunological; Peripheral Blood Stem Cell Transplantation; Receptors, CXCR4; Transplantation, Autologous; Transplantation, Homologous

2005

Other Studies

2 other study(ies) available for arginine and plerixafor

ArticleYear
Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.
    AIDS research and human retroviruses, 2000, May-01, Volume: 16, Issue:7

    Topics: Anti-HIV Agents; Antibodies, Monoclonal; Arginine; Benzylamines; Calcium Signaling; CD4-Positive T-Lymphocytes; Cell Line; Cell Survival; Cyclams; Flow Cytometry; Heterocyclic Compounds; HIV-1; Humans; Kanamycin; Receptors, CXCR4; Virus Replication

2000
NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
    Biochimica et biophysica acta, 2008, Volume: 1780, Issue:6

    Topics: Aminoglycosides; Anti-HIV Agents; Antibodies, Monoclonal; Arginine; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Gene Expression Regulation; Heterocyclic Compounds; HIV-1; Humans; Neomycin; Oligopeptides; Protein Binding; Receptors, CXCR4

2008